Analysts set Hinge Health price forecasts between $42–$47, citing high retention and growing MSK market share. Hinge’s 4.4x LTV/CAC ratio and 115%+ net-dollar retention signal strong unit ...

Barclays initiated coverage of Hinge Health Inc (NYSE: HNGE) with an overweight rating and a $43 price target on Monday. The stock, currently trading at $34.85, has experienced an 8.29% decline ...

The Society of Memorial Sloan Kettering hosted its 18th Annual Spring Ball on Tuesday, filling the storied ballroom of The Plaza Hotel with an impossibly glamorous and philanthropic crowd. This year’s ...

Hazzard first set foot in MSK nearly 40 years ago, starting as a paralegal and eventually rising to partner. After leapfrogging to various other firms for about a dozen years, he was hired in 2014 ...

Employers are facing a growing healthcare cost crisis, driven by musculoskeletal (MSK), metabolic, and mental health conditions. Chronic pain, diabetes, and stress-related issues are not just ...

Hinge Health is changing the way treatment is delivered, providing MSK care that is designed to be accessible, affordable, and completely personalized to a person’s needs.

Dr. Bob Li MSK Multinational drugmaker AstraZeneca has named Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, to the post of global head of medical ...

Several pediatric musculoskeletal (MSK) disorders exist. These include infectious types, such as osteomyelitis and septic arthritis, cancers, such as bone and soft tissue sarcomas, inflammatory ...

Virtual musculoskeletal (MSK) solutions can meaningfully improve patient outcomes, a Wednesday evaluation from the Peterson Health Technology Institute (PHTI) showed. PHTI is an independent ...

NHS England has encouraged use of a triage system for the musculoskeletal (MSK) pathway which explicitly allows rejection of GP referrals in a bid to ‘optimise capacity’. New guidance on MSK ‘referral ...